Original Publication Date: 1 June, 2014
Publication / Source: Biomarkers in Medicine
Authors: Mohamed Jalloh, Matthew R Cooperberg
Prostate cancer screening had led to the diagnosis of a large proportion of localized and low-risk disease. Many of these cancer cases are believed to be indolent and would not be clinically perceived in the absence of screening. In addition to that, the wide use of active treatment has exposed these patients to treatment-related quality-of-life impact.